Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma

PURPOSE: Cholangiocarcinoma (CCA) remains a disease with poor prognosis and limited therapeutic options. Identification of driver genetic alterations may lead to the discovery of more effective targeted therapies. CCAs harboring FGFR2 fusions have recently demonstrated promising responses to FGFR in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kongpetch, Sarinya, Jusakul, Apinya, Lim, Jing Quan, Ng, Cedric Chuan Young, Chan, Jason Yongsheng, Rajasegaran, Vikneswari, Lim, Tse Hui, Lim, Kiat Hon, Choo, Su Pin, Dima, Simona, Popescu, Irinel, Duda, Dan G., Kukongviriyapan, Veerapol, Khuntikeo, Narong, Pairojkul, Chawalit, Rozen, Steven G., Tan, Patrick, Teh, Bin Tean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193781/
https://www.ncbi.nlm.nih.gov/pubmed/32315234
http://dx.doi.org/10.1200/GO.20.00030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193781/
https://www.ncbi.nlm.nih.gov/pubmed/32315234
http://dx.doi.org/10.1200/GO.20.00030

Ejemplares similares